Your browser doesn't support javascript.
loading
Incidence of Histoplasmosis in a Cohort of People with HIV: From Estimations to Reality.
Medina, Narda; Rodriguez-Tudela, Juan Luis; Aguirre, Luis; Salazar, Luis R; Gamboa, Osmar; Bonilla, Oscar; Pérez, Juan C; Arathoon, Eduardo; Denning, David W; Alastruey-Izquierdo, Ana.
Afiliação
  • Medina N; Asociación de Salud Integral, Guatemala City 01001, Guatemala.
  • Rodriguez-Tudela JL; Global Action Fund for Fungal Infections, 01564 Geneva, Switzerland.
  • Aguirre L; Asociación de Salud Integral, Guatemala City 01001, Guatemala.
  • Salazar LR; Asociación de Salud Integral, Guatemala City 01001, Guatemala.
  • Gamboa O; Asociación de Salud Integral, Guatemala City 01001, Guatemala.
  • Bonilla O; Clínica Familiar "Luis Ángel García", Hospital General San Juan de Dios, Guatemala City 01001, Guatemala.
  • Pérez JC; Clínica Familiar "Luis Ángel García", Hospital General San Juan de Dios, Guatemala City 01001, Guatemala.
  • Arathoon E; Asociación de Salud Integral, Guatemala City 01001, Guatemala.
  • Denning DW; Clínica Familiar "Luis Ángel García", Hospital General San Juan de Dios, Guatemala City 01001, Guatemala.
  • Alastruey-Izquierdo A; Global Action Fund for Fungal Infections, 01564 Geneva, Switzerland.
Microorganisms ; 9(12)2021 Dec 16.
Article em En | MEDLINE | ID: mdl-34946197
Among people with HIV, histoplasmosis represents an important cause of mortality. Previous studies provided estimates of the disease incidence. Here, we compared those estimates with the results obtained from a screening program implemented in Guatemala, which included histoplasmosis detection for people with HIV. To compare the results of this program with previous estimations, a literature search was performed and reports concerning histoplasmosis incidence were analyzed. The screening program enrolled 6366 patients. The overall histoplasmosis incidence in the screening program was 7.4%, which was almost double that estimated in previous studies. From 2017 to 2019, the screening program showed an upward trend in histoplasmosis cases from 6.5% to 8.8%. Histoplasmosis overall mortality among those who were newly HIV diagnosed showed a decrease at 180 days from 32.8% in 2017 to 21.2% in 2019. The screening approach using rapid diagnostic assays detects histoplasmosis cases more quickly, allowing a specific treatment to be administered, which decreases the mortality of the disease. Therefore, the use of these new techniques, especially in endemic areas of histoplasmosis, must be implemented.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Revista: Microorganisms Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Guatemala País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Risk_factors_studies Idioma: En Revista: Microorganisms Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Guatemala País de publicação: Suíça